Page 1634 - Williams Hematology ( PDFDrive )
P. 1634

1608  Part XI:  Malignant Lymphoid Diseases                                Chapter 97:  Hodgkin Lymphoma             1609




                       CLINICAL AND PATHOLOGIC                          LYMPHOCYTE-RICH SUBTYPE

                     CORRELATION                                        The lymphocyte-rich subtype of cHL was introduced by the World
                                                                        Health Organization classification in 1999 (see Table  97–1) following
                                                                                                          109
                  NODULAR LYMPHOCYTE PREDOMINANCE                       an expert pathology review of cases of NLPHL.  The two subtypes dif-
                                                                        fer subtly on morphologic grounds, but the major difference is that the
                  SUBTYPE                                               Hodgkin and Reed-Sternberg cells in lymphocyte-rich cHL exhibit the
                  There is a strong correlation between age at onset, the anatomic extent   classic CD30+ CD20− immunophenotype. The presenting features are
                  of disease and histologic subtype of Hodgkin lymphoma. Approxi-  very similar although patients with the lymphocyte-rich subtype tend
                  mately 5 to 10 percent of patients present with NLPHL, which is con-  to be older compared with NLPHL patients.  A higher rate of multiple
                                                                                                        109
                  sidered to be a distinct subtype, discrete from cHL. 103,104  Progressive   relapses and a more favorable prognosis upon relapse is characteristic
                  transformation of germinal centers may precede or follow NLPHL in   of NLPHL.
                  other sites. The cellular composition is predominantly benign B lym-
                  phocytes with or without histiocytes. The characteristic multilobated,
                  CD20+ lymphocyte and histiocytic cells are relatively abundant (see   ANATOMIC DISTRIBUTION OF DISEASE
                  Chap. 96, Fig. 96–40). Patients most commonly  present  with stage  I   In approximately 70 percent of patients, cHL presents in the cervical
                  disease (70 percent) in peripheral lymph node sites, particularly in the   nodes; in 12 percent, in the axillary nodes; and in 9 percent, in the
                  axillae, and there is a 3 to 4:1 male predominance. 103,104  NLPHL may be   inguinal nodes.  A small minority of patients presents exclusively
                                                                                    110
                  associated with diffuse large B-cell non-Hodgkin lymphoma as a com-  with subdiaphragmatic disease. In an historical series of 285 consec-
                  posite tumor or a large cell lymphoma may develop at a later date. 105,106    utive,  unselected,  and  untreated  patients  evaluated  at  Stanford  Uni-
                  The large cell variant, T-cell–rich B-cell lymphoma, may be difficult to   versity, involvement of abdominal lymph nodes and the spleen was
                  distinguish from NLPHL and may occur concurrently or subsequently   documented in 272 upon laparotomy, a surgical diagnostic procedure
                  (Chap. 98). 107                                       in which the intraabdominal and pelvic lymph nodes are biopsied, the
                                                                        spleen is removed and examined pathologically in thin slices, the liver
                  NODULAR SCLEROSIS SUBTYPE                             is biopsied by needle and wedge technique, and the marrow is biop-
                  cHL is characterized by Hodgkin and Reed-Sternberg cells that express   sied. The frequency of splenic involvement at laparotomy in untreated
                                                                        patients averaged 37 percent in 17 published series.  Involvement of
                                                                                                              110
                  CD30 and CD15+ but usually not typical B-cell surface markers such as   the spleen was strongly dependent on histologic subtype: it was involved
                  CD20 or CD79B. The nodular sclerosis subtype constitutes 40 to 70 per-  in 60 percent of mixed cellularity and lymphocyte-depleted cases com-
                  cent of cHL and is distinguished by its distinctive clinical and histologic   pared with 34 percent of nodular lymphocyte-predominant and nodular
                  features. This subtype typically involves lower cervical, supraclavicular,   sclerosis cases. Hepatic and marrow disease were invariably associated
                  and mediastinal lymph nodes in adolescents and young adults, partic-  with splenic involvement.
                  ularly females. Approximately 70 percent of patients with the nodular   Two different theories, the “contiguity” theory of Kaplan and
                  sclerosis subtype present with limited stage disease. A characteristic his-  Rosenberg  and the “susceptibility” theory of Smithers,  have been
                                                                                111
                                                                                                                  112
                  tologic feature is the lacunar cell, a Reed-Sternberg variant that results   proposed for the mode of spread of cHL. In support of the former, most
                  from retraction of the cytoplasm of Hodgkin and Reed-Sternberg cells   cases of cHL appear to spread via lymphatic channels to contiguous
                  during formalin fixation (see Chap. 96, Fig. 96–38). Another typical fea-  lymphatic structures in a predictable, nonrandom pattern. Controversy
                  ture is the thickened capsule and fibrous bands that divide the lymphoid   has surrounded the mode of spread to the spleen, which lacks affer-
                  tissue into cellular nodules.
                                                                        ent lymphatics. When four or more lymph node regions are involved,
                                                                        spread by hematogenous distribution appears likely. Disseminated dis-
                  MIXED CELLULARITY SUBTYPE                             ease  is  more  common  in  mixed  cellularity  and  lymphocyte-depleted
                                                                                                                          113
                  Mixed cellularity cHL involves both pediatric and older age groups   cases, consistent with the presence of reported vascular invasion.
                  and is more commonly associated with advanced stage disease, con-  Whereas vascular invasion is controversial, it is more common in the
                                                                                                                   114
                  stitutional symptoms, and immunodeficiency. Approximately 30 to   spleen than in lymph nodes and connotes a poor prognosis.
                  50 percent of patients present with this histology. Classic Hodgkin and
                  Reed-Sternberg cells are easily found amid a cellular background com-  STAGING
                  posed of lymphocytes, eosinophils, plasma cells, and histiocytes (see
                  Chap. 96, Fig. 96–39). A worse prognosis has been reported for this   Optimal management of Hodgkin lymphoma relies on knowledge of
                  subtype. 108                                          the extent of disease dissemination, which is determined by performing
                                                                        a careful physical examination, supplemented by laboratory tests and
                                                                        radiographic imaging studies (Chap. 95). This process, known as “stag-
                  LYMPHOCYTE-DEPLETED SUBTYPE                           ing,” has been refined by a series of international working groups. The
                  Lymphocyte-depleted cHL has two morphologic variants: reticular   current 2014 Lugano staging system  is a refinement of the historical
                                                                                                   94
                  and diffuse fibrosis. The reticular variant contains abundant pleomor-  Ann Arbor classification  and assigns patients to one of four stages as
                                                                                          15
                  phic neoplastic cells whereas the diffuse fibrosis variant has a promi-  indicated in Table 97–2. The classification for Hodgkin lymphoma is
                  nent fibroblastic proliferation with few normal lymphocytes. Hodgkin   further refined by designating the presence or absence of constitutional
                  and Reed-Sternberg cells are sparse. The lymphocyte-depleted subtype   “B” symptoms (fever >38°C, weight loss >10 percent of body weight,
                  presents in older patients with symptomatic, extensive disease, and may   or drenching night sweats). Extranodal disease, representing extracap-
                  be associated with fever of unknown origin, jaundice, hepatosplenomeg-  sular extension of lymph node disease that could be incorporated in a
                  aly, or pancytopenia. Peripheral and mediastinal adenopathy is much   standard radiotherapy field, is distinguished from disseminated, stage
                  less common than in other subtypes. Cases of cHL developing in the   IV disease. The correlation of this staging classification system with
                  setting of HIV typically exhibit the lymphocyte-depleted morphology.  prognosis  was extensively  verified when  radiotherapy served as the






          Kaushansky_chapter 97_p1603-1624.indd   1609                                                                  9/18/15   11:12 PM
   1629   1630   1631   1632   1633   1634   1635   1636   1637   1638   1639